Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: The smoker's paradox revisited

European Heart Journal

Volumn 37, Issue 36, 2016, Pages 2756-2764

  Symons, Rolf ^a   Masci, Pier Giorgio ^b   Francone, Marco ^c   Claus, Piet ^a   Barison, Andrea ^d   Carbone, Iacopo ^c   Agati, Luciano ^c   Galea, Nicola ^c   Janssens, Stefan ^a   Bogaert, Jan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

Cardiovascular risk factors; Left ventricular remodelling; Myocardial infarction; Smoker's paradox

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL SALVAGE INDEX; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPERFUSION INJURY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; RISK FACTOR;

HUMANS; RISK FACTORS; SMOKERS; SMOKING; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84992202151     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv738     Document Type: Article

References (24)

1. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: The Framingham study. Am J Public Health 1951;41:279-286.
2. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: The Framingham offspring study. Am J Epidemiol 1979;110:281-290.
3. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356: 830-840.
4. Masci PG, Ganame J, Strata E, DesmetW, Aquaro GD, Dymarkowski S, Valenti V, Janssens S, Lombardi M, Van deWerf F, L'Abbate A, Bogaert J. Myocardial salvage by CMR correlates with LV remodelling and early ST-segment resolution in acute myocardial infarction. JACC Cardiovasc Imaging 2010;3:45-51.
5. Eitel I, Desch S, Fuernau G, Schulz-Menger J, Messroghli D, Dietz R. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1581-1587.
6. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, DesmetW, Van deWerf F, Bogaert J. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009;30:1440-1449.
7. Symons R, Masci PG, Goetschalckx K, Doulaptsis K, Janssens S, Bogaert J. Effect of infarct severity on regional and global left ventricular remodelling in patients with successfully reperfused ST segment elevation myocardial infarction. Radiology 2015; 274:93-102.
8. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, Gutberlet M, Schuler G, Friedrich MG, Thiele H. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction. Circ Cardiovasc Imaging 2011;4: 354-362.
9. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S. Reperfusion hemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart 2011;97: 453-459.
10. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
11. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
12. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Hypertension 2003; 42:1206-1252.
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-3421.
14. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998;6(Suppl. 2):S51-S210.
15. Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
16. Carrick D, Haig C, Rauhalammi S, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Watkins S, Hood S, Davie A, Mahrous A, Sattar N, Welsh P, Tzemos N, Radjenovic A, Ford I, Oldroyd KG, Berry C. Pathophysiology of LV remodelling in survivors of STEMI: inflammation, remote myocardium, and prognosis. JACC Cardiovasc Imaging 2015;8:779-789.
17. van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. J Am Coll Cardiol Img 2014;7:930-939.
18. Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985;110:535-541.
19. Gupta T, Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Jain D, Sule S, Ahmed A, Iwai S, Eugenio P, Lessner S, Frishman WH, Panza JA, Fonarow GC. Relation of smoking status to outcomes after cardiopulmonary resuscitation for inhospital cardiac arrest. Am J Cardiol 2014;114:169-174.
20. Verouden NJ, Haeck JD, Kuijt WJ, Meuwissen M, Koch KT, Henriques JP, Baan J, Vis MM, Piek JJ, Tijssen JG, de Winter RJ. Clinical and angiographic predictors of ST-segment recovery after pPCI. Am J Cardiol 2010;105:1692-1697.
21. Basso C, Corbetti F, Silva C, Abudureheman A, Lacognata C, Cacciavillani L, Tarantini G, Marra MP, Ramondo A, Thiene G, Iliceto S. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol 2007;100:1322-1327.
22. Eitel I, deWaha S, Wö hrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014;64:1217-1226.
23. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010;9:728-743.
24. Kali A, Tang RL, Kumar A, Min JK, Dharmakumar R. Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging. Radiology 2013;269: 387-395.